@article{434758a893284a0fba3c64c50e7c9148,
title = "Treatment of Pityriasis Rubra Pilaris with Guselkumab",
author = "Pilz, \{Anna Caroline\} and Peter Seiringer and Tilo Biedermann and Kilian Eyerich",
note = "Funding Information: Conflict of Interest Disclosures: Dr Pilz reports personal fees and non-financial support from AbbVie Deutschland GmbH and nonfinancial support from ALK-Abell{\'o} Arzneimittel GmbH outside the submitted work. Dr Seiringer reports nonfinancial support from Janssen-Cilag and AbbVie and personal fees from Bristol-Myers Squibb and Celgene outside the submitted work. Dr Biedermann reports grants and personal fees from ALK-Abell{\'o}, Celgene, Mylan, Novartis, Thermo Fisher Scientific, and Sanofi-Regeneron outside the submitted work. Dr Eyerich reports personal fees and nonfinancial support from AbbVie, Almirall, Hexal, Lilly, Sanofi and Bristol-Myers Squibb; grants, personal fees, and nonfinancial support from Celgene, Janssen, and Novartis; and grants and nonfinancial support from Galapagos outside the submitted work.",
year = "2019",
month = dec,
doi = "10.1001/jamadermatol.2019.2774",
language = "English",
volume = "155",
pages = "1424--1426",
journal = "JAMA Dermatology",
issn = "2168-6068",
publisher = "American Medical Association",
number = "12",
}